Tablica mendeleeva v vektore live. Jan 23, 2018 - Torrent Pharmaceuticals Ltd. (Vista) brand List that includes tablets, capsules, syrups, etc. Brands listed with corresponding Generic name.
• Baddi Plant received OHAS Audit certification; facility approved by the regulatory authority of Uganda • An advanced facility for Stability Studies set up at Indrad Plant • Entered into the therapeutic area of Gynaecology • Commenced commercial operations of Laboratories Torrent S.A. De C.V., Mexico • Started construction of Dahej manufacturing facility • Commissioned a subsidiary in United Kingdom and Romania • Torrent Research Center develops Long Acting Injectables technology • Foray into oncology segment •. • New manufacturing unit at Baddi, Himachal Pradesh, set up to cater to domestic formulations market. • Torrent Pharma signed an agreement with Novo Nordisk India to establish a new, dedicated formulation and packaging facility for Insulin, exclusively for Novo Nordisk.
• Acquired Heumann Pharma GmbH & Co Generica KG, a Pfizer group company, in Germany. • Two new marketing divisions- AXON and NEURON set up to cater to neuropsychiatry segment. • Entered into a research collaboration with AstraZeneca for developing novel anti-hypertensive drug.
• Torrent Pharma's QC department at Chhatral manufacturing plant accredited with ISO/IEC- 17025 by NABL •. • Discovered and patented AGE (Advanced Glycosylation End-products) molecule. • Torrent Pharma's Indrad Plant receives ISO and OHSAS • Torrent's R&D Centre received ISO/IEC for its facilities by National Accreditation Board for Testing and Calibration Laboratories (NABL). • Addition of a new marketing division, MIND • Dual Retard Inlay Technology, Compact Tablet Technology, Gastro Retentive System and Multiparticulate / Matrix Based SR / Modified Release Formulations developed indigenously by Torrent Research Center (2002) • Torrent Pharma bagged the Gold Trophy for IDMA Quality Excellence Award 2003 for both Formulations and API manufacturing facilities • Brazilian Sanitary Surveillance Agency accredited Torrent's R&D Centre with ANVISA, authorizing it to conduct Bioequivalance Studies.
- Author: admin
- Category: Category
Tablica mendeleeva v vektore live. Jan 23, 2018 - Torrent Pharmaceuticals Ltd. (Vista) brand List that includes tablets, capsules, syrups, etc. Brands listed with corresponding Generic name.
• Baddi Plant received OHAS Audit certification; facility approved by the regulatory authority of Uganda • An advanced facility for Stability Studies set up at Indrad Plant • Entered into the therapeutic area of Gynaecology • Commenced commercial operations of Laboratories Torrent S.A. De C.V., Mexico • Started construction of Dahej manufacturing facility • Commissioned a subsidiary in United Kingdom and Romania • Torrent Research Center develops Long Acting Injectables technology • Foray into oncology segment •. • New manufacturing unit at Baddi, Himachal Pradesh, set up to cater to domestic formulations market. • Torrent Pharma signed an agreement with Novo Nordisk India to establish a new, dedicated formulation and packaging facility for Insulin, exclusively for Novo Nordisk.
• Acquired Heumann Pharma GmbH & Co Generica KG, a Pfizer group company, in Germany. • Two new marketing divisions- AXON and NEURON set up to cater to neuropsychiatry segment. • Entered into a research collaboration with AstraZeneca for developing novel anti-hypertensive drug.
• Torrent Pharma's QC department at Chhatral manufacturing plant accredited with ISO/IEC- 17025 by NABL •. • Discovered and patented AGE (Advanced Glycosylation End-products) molecule. • Torrent Pharma's Indrad Plant receives ISO and OHSAS • Torrent's R&D Centre received ISO/IEC for its facilities by National Accreditation Board for Testing and Calibration Laboratories (NABL). • Addition of a new marketing division, MIND • Dual Retard Inlay Technology, Compact Tablet Technology, Gastro Retentive System and Multiparticulate / Matrix Based SR / Modified Release Formulations developed indigenously by Torrent Research Center (2002) • Torrent Pharma bagged the Gold Trophy for IDMA Quality Excellence Award 2003 for both Formulations and API manufacturing facilities • Brazilian Sanitary Surveillance Agency accredited Torrent's R&D Centre with ANVISA, authorizing it to conduct Bioequivalance Studies.